RxDoctor Payments Data

Clyde Bancroft, PA

Physician Assistant · Roseburg, ORNPI 1841397742

Payments from drug & device makers

$521in general payments, 2019–2025

Across 32 payments — averaging $16.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$88
  • AbbVie$73
  • GSK$72
  • Novartis$67
  • Kowa Pharmaceuticals America, Inc.$56
  • Tactile Systems Technology Inc$25
  • plus $140 from 8 others

What the payments were for

  • Food & beverage$521100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$521 in reported general payments places this provider in the 75th percentile of 1,756 physician assistant providers in Oregon.

See all physician assistant providers in Oregon

Medicare billing

Part B allowed, 2024
$2,734
Medicare patients
55
Services billed
89

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban158$193,008
OzempicSemaglutide78$95,643
XareltoRivaroxaban69$67,069
JardianceEmpagliflozin29$30,993
JanuviaSitagliptin Phosphate13$21,112
NucyntaTapentadol Hcl16$14,806
Semglee (Yfgn) PenInsulin Glargine-Yfgn26$14,303
OxycontinOxycodone Hcl26$14,111
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate39$7,900
Atorvastatin Calcium455$6,770
Spiriva RespimatTiotropium Bromide13$6,672
Fluticasone-SalmeterolFluticasone Propion/Salmeterol41$6,003
Gabapentin258$5,933
Tamsulosin Hcl260$5,407
ShingrixVaricella-Zoster Ge/As01b/Pf24$5,229

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$88$95,64378 claims
Johnson & JohnsonXarelto$15$67,06969 claims
GSKShingrix, Breo Ellipta$72$10,09836 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,756 physician assistant providers in Oregon.

Other physician assistant in Roseburg

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →